Tag | Content |
---|
EnhancerAtlas ID | HS017-26197 |
Organism | Homo sapiens |
Tissue/cell | CD14+_monocyte |
Coordinate | chr5:53971580-53973430 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr5:53972159-53972180 | GAAGAGAAACAGAAAACAAAA | - | 6.15 | Nkx3-2 | MA0122.3 | chr5:53973245-53973258 | ATTAAGTGGTTTT | - | 7.22 | STAT1 | MA0137.3 | chr5:53973045-53973056 | TTTCTAGGAAA | + | 6.14 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_01783 | chr5:53971565-53972089 | Aorta | SE_01783 | chr5:53972146-53973247 | Aorta | SE_10074 | chr5:53971510-53973415 | CD14 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr5 | 53971615 | 53971811 | chr5 | 53972314 | 53972697 |
|
| Number: 2 | ID | Chromosome | Start | End |
GH05I054675 | chr5 | 53971615 | 53971811 | GH05I054676 | chr5 | 53971830 | 53972697 |
|
Enhancer Sequence | CCTATGCTGT ACTAGGAGAG CCTGGGAGAG AACTCTGTTT AGAAATAAAC AAGCCCAGGG 60 ATTGCCATCT ATTTGCCCTG TATTCACTTG GACTTATTTA TCATAGTGCT TTTTCAAACT 120 GTGTTCAAAA CTCCCTGGGG TTTTCCAGAG GTGCTTTAGA GACCCAATTC AACCATGTTG 180 GCCTATTTTG GACAAACAAA GGCTTGAAAA TCACCAGCAT ACCTTTTCAC AGTGTACATG 240 CTCTGTCCGA GGTCCAGTGC TCTTGGTGGT TATTAAAAGT GGATTTGTGT GTGTGTATCA 300 AGACTGCCAC GCACTCTCAG AAGTTCACTC TGTGCCCCCC TTCAAGCCCC TCTTGAAGAC 360 AGGAATCTCT CTATTTCTGG TTGTTCTGCC CCTGCCCTCC CTACCTAAAT CCAGACCCTA 420 CTCAAAAAGG AAAATGGTTT CTCAGCATTC CTCCCCATGT TCATTATCTG GCAGCTCTTC 480 TCTGGAGGTT GGAAAGAATT AATCCATTAT TGTTGTCAAC ACAATCATAA TAAGGCATGA 540 AAATGAAGTG ATGAGATCTT TTTTTCAGTC AAACCTCTTG AAGAGAAACA GAAAACAAAA 600 ACAGCATTTT ATCTTTGACT AGAATGATTA TTTCTCAAAG GAAATAACTT CAGTCCCGTA 660 CTTTGTGGGA GGAAAGGCAC AAGATGTGGA GGATGTCCAG GCACTGTGCC TGGCTCACAG 720 ACATTGTTCA TAAATGTTTG GTTCATAGTT TCTTTCATTC ATTCTATAAA CATAAACTCT 780 GATCTCTAGG AGGAGGATTT TATTTGCCTC TTGAACTATC TCTTGACAAA GCCAAGTCAC 840 CACACAAATG ATGCAGGCAA CTGCCAGCTG GTTTGCAAAT TTCCTGAGTT GCCCAAGTAC 900 AGCACAGTGA GCATGAAAAT CAAAGGCTCT CAAACCTGGA AGGAACCTTT AAAAATGACC 960 CGAGGTCAAT TGCCCAGGAA AATCCCTGCC AAGTGCTGCA AGTTGAGGTT GGAAGTGTCC 1020 AGTCTCTCTG ATGCAGCCAA GTCTGTCTTT GGACAACTCT GTTAGAAGGC TCTTCCTGAT 1080 ATTGAATTGA AATCTATCAC TTCATAGCTT TTCTTTATTC CTCCAATAAA TCCTGTATGA 1140 GAGACCAGGA GGCAGAACAG AATCATTCAA ATCCTCCTTC TTGGCAATCT GTTGAATATT 1200 GGAAGACAGG GGCCAAGTTC TCTGAGTCTT CTTTTCTCCA AGGCCTCTGT CTCCTAATCT 1260 TTCAAACATT TCCATGGGAT AAGATTTTCA AATTATCTTG GTCCTTTTCC CATTAAGAAG 1320 CTTTACTTTT CTACTCTTAA AATAGGCTGC CTAGAATAGA AATAATTCCA TGTGACTTAA 1380 CTAGCGCAGA AAGGAACAGA CTCTGCTAAA TCTGATTTCA GAGACTGCCA CTCACTAGCA 1440 GCGTGGCTTT GGCAAGTTAC TTCCCTTTCT AGGAAACATG GTTTAATATG TAGCCTCAAG 1500 TAAAGTGCCT ACTACAGTGC CTGGCATAAA GGGGTGTCAA TACCTGATAT CTACCTATCA 1560 ATTGCTATTA TTCTTCTGTC AATGCAGTTT CAGGTGGCAC TAGACCTTAA GGTGATAACA 1620 TCACACTATT GACTCCTAGG TTTTACCCAC AAGTAAATTC AGAGTATTAA GTGGTTTTAA 1680 TCCATGGCTC CCCCATCCTT TACTCACATT GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT 1740 GTGTGTGCCT AAGCATCAAA ATTTCCATTT ATCTTATAAA ATTGTATTTG TTCAATTCAG 1800 GTCATTGTTT AATGTGAGCA AATTTAATGA ACAAGACTCT ATCTTTTTAT 1850
|